Loading candles…
Arvee Laboratories India Ltd, incorporated in 2012, operates in the chemical and pharmaceutical industries. The company manufactures specialized chemicals primarily used in the pharmaceutical sector, including pharmaceutical intermediates, specialty chemicals, and Thiophene-2-Ethanol along with its derivatives. It emphasizes cost-efficient manufacturing and quality-driven process optimization. Arvee Laboratories maintains a niche presence in the chemical sector and focuses on the development and production of chemicals used in pharmaceuticals. The company serves both domestic and international markets. There are no publicly listed subsidiaries or ventures, and no information is provided regarding founders, key management, headquarters, or stock exchange listings.
This page is a live market overview for ARVEE LABORATORIES I LTD (ARVEE) on the NSE. As a listed security, ARVEE LABORATORIES I LTD is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ARVEE before placing trades on tick2trade.
As of the latest feed, ARVEE last traded at ₹240.8 on NSE, up ₹4.73 (2.00%) from the previous close of ₹236.07. Today's session range is ₹231.2 – ₹255, against a 52-week band of ₹129.11 – ₹290.78. Traded volume today stands at 52.69K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for ARVEE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ARVEE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ARVEE LABORATORIES I LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ARVEE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ARVEE option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 7 Aug 2026 |
| Results - FY26 | ARVEE : 19-May-2026 : The Company has informed the Exchange that a Board meeting to be held on May 18, 2026 has been re-scheduled. Further, the Company has … | 19 May 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and other business matters | 18 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 13 Feb 2026 |
| Results - FY25 | ARVEE : 14-Nov-2025 : The Company has informed the Exchange that a Board meeting to be held on November 13, 2025 has been re-scheduled. Further, the Company… | 14 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 13 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 12 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and other business matters | 9 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.